Abstract:Introduction: The reported relationship between coffee intake and renal function is poorly understood. By applying two-sample Mendelian randomization (MR) and systematic review and meta-analysis we investigated the association of caffeine and coffee intake with prevalent CKD and markers of renal function. Material and methods: For the individual data analysis we analyzed the National Health and Nutrition Examination Surveys (NHANES) data on renal function markers and caffeine intake. MR was implemented by using summary-level data from the largest ever genome-wide association studies (GWAS) conducted on coffee intake (N = 91,462) and kidney function (N = 133,413). The inverse variance weighted method (IVW), weighted median-based method, MR-Egger, MR-RAPS, and MR-PRESSO were applied. Random effects models and generic inverse variance methods were used to synthesize quantitative and pooled data for the meta-analysis, followed by a leave-one-out method for sensitivity analysis. Results: Finally, we included the data of 18,436 participants; 6.9% had prevalent CKD (based on eGFR). Caffeine intake for the general population was 131.1 ±1.1 mg. The percentage of participants with CKD, by caffeine quartile, was 16.6% in the first (lowest) quartile, 13.9% in the second, 12.2% in the third and 11.0% in the top quartile (p < 0.001). After adjustment, for increasing quartiles for caffeine consumption, mean urine albumin, albumin-creatinine ratio and estimated glomerular filtration rate (GFR) did not change significantly (p > 0.234). In fully adjusted logistic regression models, there was no significant difference in chances of CKD prevalence (p-trend = 0.745). In the same line, the results of MR showed no impact of coffee intake on CKD (IVW: β = -0.0191, SE = 0.069, p = 0.781) or on eGFR (overall = IVW: β = -0.0005, SE = 0.005, p = 0.926) either in diabetic (IVW: β = -0.006, SE = 0.009, p = 0.478) or non-diabetic patients (IVW: β = -6.772, SE = 0.006, p = 0.991). Results from the meta-analysis indicated that coffee consumption was not significantly associated with CKD (OR = 0.85, 95% CI: 0.71-1.02, p = 0.090, n = 6 studies, I 2 = 0.32). These findings were robust in sensitivity analyses. Conclusions: Implementing different strategies, we detected no significant association between coffee consumption and renal function or risk of CKD.

The impact of genetic variability on the relationship between caffeine and cardiometabolic outcomes: A systematic review

Impact of Genetic Variability on Physiological Responses to Caffeine in Humans: A Systematic Review

Genetic investigation into the broad health implications of caffeine: evidence from phenome-wide, proteome-wide and metabolome-wide Mendelian randomization

CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study

Coffee Intake and Risk of Diabetic Nephropathy: a Mendelian Randomization Study

Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption

Novel insights on caffeine supplementation, CYP1A2 genotype, physiological responses and exercise performance

The effect of caffeine on cognitive performance is influenced by CYP1A2 but not ADORA2A genotype, yet neither genotype affects exercise performance in healthy adults

Habitual Coffee Consumption Increases Risks for Metabolic Diseases: Genome-wide Association Studies and a Phenotype-wide Two Sample Mendelian Randomization Analysis

Caffeine Intake, Plasma Caffeine Level, and Kidney Function: A Mendelian Randomization Study

Coffee Types and Cardiac Metabolic Risks: Large-scale Cross-phenotype Association Study and Mendelian Randomization Analysis

Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk

Prognostic cardiovascular cut-off values of dietary caffeine in a cohort of unselected men and women from general population

Genetic and Causal Relationship Between Coffee Intake and Cardiometabolic Risks: Cross-Phenotype Association And Mendelian Randomization Analysis

Coffee consumption and cardiometabolic health: a comprehensive review of the evidence

Habitual Coffee and Tea Consumption and Cardiometabolic Biomarkers in the UK Biobank: The Role of Beverage Types and Genetic Variation

The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis

CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance

Characterization of caffeine response regulatory variants in vascular endothelial cells

Potential genetic association between coffee/caffeine consumption and erectile dysfunction: a Mendelian randomization study and meta-analysis